Zantac and ranitidine are routinely used by millions of heartburn sufferers. ... The regulatory agency wants manufacturers to test and recall the drugs if NDMA levels exceed its standards.

The agency is testing Zantac and its generic versions but has not asked drugmakers to recall the products. Sanofi, which makes the brand-name drug Zantac, has no plans to halt shipments in the USA.

Aurobindo Pharma USA, Inc. is the latest company to issue a voluntary recall of ranitidine products over concerns regarding "probable" carcinogen NDMA.

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

There are now nearly a dozen recalls for the generic version of Zantac since late September for a potential cancer-causing impurity.

Zantac and ranitidine have made a lot of headlines recently, ... Sandoz and Apotex Corp. to voluntarily recall the drugs—is the administration being very cautious," he continues. ...

The FDA has requested all ranitidine (Zantac) products be pulled from the market immediately. The recall includes all prescription and over-the-counter ranitidine drugs as ongoing investigations ...

More prescription-strength and hospital-used ranitidine, sold over the counter under the brand name Zantac, has been recalled for having too much of carcinogen NDMA. Though the run of recalls on ...

Denton Pharma Inc. this week recalled several batches of ranitidine tablets. The recall impacts all unexpired lots of 150 mg and 300 mg tablets. The pills were distributed to Northwind ...

The FDA is also advising consumers taking OTC ranitidine to stop taking any tablets or liquid they currently have, dispose of them properly and not buy more. Don't Edit American Health Packaging ...

A voluntary recall of a generic version of Zantac has been issued because the drug has been found to contain a contaminant that could cause cancer. Sandoz Inc. is recalling 14 lots of prescription ...

Another recall has been issued for a generic version of a popular heartburn drug best known as Zantac due to the presence of a potentially cancer-causing impurity. It's the latest in several such ...